Form 4 for ELAN Elanco Animal Health Inc
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0001415889-24-005977 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-29 | 2024-02-27 | ELAN | Kinard David S | SEE REMARKS | A - Grant | $0.00 | +14.6K | 146.4K | +11% | $0 | |
| 2024-02-29 | 2024-02-27 | ELAN | Kinard David S | SEE REMARKS | F - Tax | $16.46 | -6,625 | 139.8K | -5% | -$109.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-27 | A | A | 14,562 | $0.00 | 146,406 | D | — | — | (F1) Includes 632 shares acquired on March 31, 2023, 591 shares acquired on June 30, 2023, 529 shares acquired on September 29, 2023 and 399 shares acquired on December 29, 2023, under Elanco Animal Health Inc.'s Employee Stock Purchase Plan . |
| 2 | Common | Common Stock | 2024-02-27 | F | D | 6,625 | $16.46 | 139,781 | D | — | — |